FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Feb 26, 2013
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on February 26, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- February 26, 2013
- Product Type
- Biologics
View Company Profile
ID · cf74a144-bcc0-4fc9-bfaa-51f2aee60463
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 820154
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.60(a)Maintain and clean equipment
- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 10, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1023216 - 2017-08-14
- FDA Inspection 726568 - 2011-05-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.